About: Amanda J Leach

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Amanda J Leach Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Australian microbiologist

Attributes	Values
rdf:type	Item
field of work	wds:Q89364775-9d376731-4e46-5d61-efe9-32a6b89e3663
field of work	ear disease
description	ikertzailea (eu) дослідник (uk) эрдэмтэн (mn) onderzoeker (nl) Australian microbiologist (en)
rdfs:label	Amanda J Leach (en) Amanda J Leach (nl)
skos:prefLabel	Amanda J Leach (en) Amanda J Leach (nl)
name	Amanda J Leach (en) Amanda J Leach (nl)
LinkedIn personal profile ID	wds:Q89364775-6ca0dc54-40cd-354a-0a1b-df6e15286031
LinkedIn personal profile ID	amanda-jane-leach-am-a4a78a44
given name	wds:Q89364775-151f19f8-46a5-7e43-c1f8-5f7d2e33e432 wds:Q89364775-15B4A66C-4B4F-4732-ACA1-F5CC038A0BF1
given name	Jane Amanda
instance of	wds:Q89364775-EC78F502-C178-45B5-9917-9CAC208AA799
instance of	Homo sapiens
award received	wds:Q89364775-9259364c-4664-d5ab-26f6-f4f91cf04b77
award received	Member of the Order of Australia
Loop ID	wds:Q89364775-8b282250-4411-fce5-bfe7-dab88bb7b043
Loop ID	1729700
skos:altLabel	Amanda Leach (en) Amanda J. Leach (en) Amanda Jane Leach (en)
occupation	wds:Q89364775-7f8dccd6-48ee-fd4d-2f57-c903012cb9c5
employer	wds:Q89364775-38606A4B-F759-48F8-85B8-F30D2A6E315F wds:Q89364775-A37F1DDF-ABD2-407F-A455-BFC532252936
NLA Trove people ID	wds:Q89364775-af01777e-4ff9-dafd-55b5-9a0148c3fe5b
sex or gender	wds:Q89364775-26bc4e24-4b07-2207-c3cb-c1735d31a606
date of birth	wds:Q89364775-630ff525-48cc-f5c4-6486-ade3148182c7
educated at	wds:Q89364775-248bd5ae-4987-4711-47af-aec0ff01f06d wds:Q89364775-84CB09A4-3CC8-4AD0-8328-BC0C990B54DC
family name	wds:Q89364775-F6AFAB32-892F-4D96-8273-C7C6041E3AB1
occupation	microbiologist
employer	Charles Darwin University Menzies School of Health Research
NLA Trove people ID	546330
sex or gender	female organism
date of birth	1954-01-01 00:00:00Z (xsd:dateTime)
educated at	University of Sydney La Trobe University
family name	Leach
ORCID iD	wds:Q89364775-A9E05233-729D-4F4C-90D2-6AAF2D39B7CE
Dimensions author ID	wds:Q89364775-F7D094B4-7A5A-43F7-816B-6A946A16F83A
ORCID iD	https://orcid.org/0000-0002-4638-8392
ORCID iD	0000-0002-4638-8392
Dimensions author ID	07773120367.25
ResearcherID	wds:Q89364775-ADA2901E-8BC4-4176-B828-621008854E5E
ResearcherID	N-2311-2013
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q89364775
is author of	A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS. Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children Four year immunogenicity of the RTS,S/AS02(A) malaria vaccine in Mozambican children during a phase IIb trial. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trial Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya. Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial. Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines. Is early surgical referral for children with persistent otitis media with effusion (OME) appropriate? Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa A community-based service enhancement model of training and employing Ear Health Facilitators to address the crisis in ear and hearing health of Aboriginal children in the Northern Territory, the Hearing for Learning Initiative (the HfLI): study pro Otitis media guidelines for Australian Aboriginal and Torres Strait Islander children: summary of recommendations Hearing loss among Australian Aboriginal infants and toddlers: A systematic review Randomised controlled trial of perinatal vitamin D supplementation to prevent early-onset acute respiratory infections among Australian First Nations children: the ‘D-Kids’ study protocol Impact of hearing impairment on early childhood development in Australian Aboriginal children: A data linkage study Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial
is author of	wds:Q35925829-4365925F-D60A-43DE-9038-DEF230E7E7E4 wds:Q46182948-58A1582F-25CD-43E7-B5FE-D095DF6B326A wds:Q36041729-37EA321C-81A2-4757-BCDA-080D636749A7 wds:Q35016669-48F3A8B0-5681-41F5-ADF2-FBDB704EF897 wds:Q38380487-C7D4DF2B-E668-4DC4-A810-5BA4539725EB wds:Q64125345-86F58825-1E6B-4EF3-AF15-655538E675A3 wds:Q119907919-0732D94D-D531-42A4-9A9B-F0AC31F0CDD9 wds:Q35198729-631E51D2-BEA3-4824-81A0-90A34E0FEABD wds:Q33981953-9DE1670F-225D-4D28-9F44-EF6AD4A9DE1A wds:Q34359432-65E7A589-808A-422D-A20E-9B765387052D wds:Q28748565-B64D17CD-2202-42E4-8DE6-15D57D9F9825 wds:Q46884256-1890050C-3F84-4915-AD05-0C7E67CEED80 wds:Q79164969-D0637B90-E2F3-42BE-A767-40E05EF46EF5 wds:Q115290427-FD5FF0C1-EE8E-4C04-A108-11207E6FE3C4

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software